INIS
patients
54%
thrombin
38%
fibrin
37%
risks
32%
thrombosis
28%
proteins
26%
collagen
26%
receptors
23%
therapy
23%
blood
22%
diseases
20%
glycoproteins
20%
tissues
19%
kinases
17%
plasma
16%
fibrinogen
15%
surfaces
12%
reviews
12%
populations
11%
coronaries
11%
adhesion
11%
control
11%
mice
11%
levels
10%
interactions
10%
cancer
9%
laboratories
9%
aggregation
9%
hemostatics
9%
inhibition
8%
Keyphrases
Platelets
100%
Thrombus Formation
48%
Platelet Activation
26%
Thrombin Generation
23%
Coagulation
20%
Platelet Function
20%
Thrombosis
20%
Thrombus
19%
Tissue Factor
16%
Collagen
16%
Whole Blood
15%
Bleeding Risk
13%
Fibrin Formation
12%
Glycoprotein VI
12%
Fibrin
12%
Thrombin
12%
Hemostasis
12%
Platelet Adhesion
11%
Fibrinogen
10%
Bleeding
9%
Atherothrombosis
9%
Coagulation Factors
9%
Platelet Thrombus
9%
Von Willebrand Factor
8%
Phosphatidylserine Exposure
8%
Integrin αIIbβ3
7%
Antithrombotic Therapy
7%
Flow Condition
7%
Activated Platelets
7%
Clinical High Risk
7%
Medicine and Dentistry
Platelet
60%
Blood Clotting
46%
Thrombosis
25%
Thrombus
18%
Bleeding
16%
Thrombocyte Activation
15%
Thrombocyte Function
13%
Thrombin
12%
Blood Stasis
11%
Hemostat
10%
Thrombocyte Adhesion
9%
Cardiovascular Disease
9%
Von Willebrand Factor
8%
Antithrombotic Therapy
8%
Fibrin Clot
7%
Antithrombotic
7%
Antiplatelet
7%
Thromboplastin
6%
Integrin
6%
Blood Clotting Factor
6%
Fibrin Formation
6%
Receptor
6%
Glycoprotein VI
6%
Thrombocyte Dysfunction
5%
Procoagulant
5%
Atherosclerosis
5%
Disease
5%
Percutaneous Coronary Intervention
5%
Polycythemia vera
5%